All In Biotech

Free tool

FAERS Monitor: Gattex Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203441 or its brand name (Gattex Kit, Teduglutide). Reports on generic versions are filed under their own applications.

Reports

13,437

Serious

11,269

84% of reports

Hospitalization

8,033

Death reported

1,153

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • weight decreased1,267
  • vascular device infection1,178
  • nausea1,106
  • product dose omission issue1,074
  • abdominal pain1,070
  • diarrhoea1,061
  • weight increased882
  • dehydration876
  • vomiting852
  • death778
  • abdominal distension726
  • pyrexia632
  • hospitalisation590
  • inappropriate schedule of product administration546
  • decreased appetite531

Reports by year received

View as table
YearReports
20091
20101
201340
2014273
2015510
2016370
2017369
20181,131
2019864
20201,130
20212,005
20222,075
20231,685
20241,305
20251,113
2026565

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,722 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vascular device infectionSignal1,178548.5514.4476,471
abdominal distensionSignal72611.010.26,545
dehydrationSignal87610.39.77,381
abdominal painSignal1,0707.26.85,773
weight decreasedSignal1,2677.16.86,733
weight increasedSignal8826.25.83,855
hospitalisationSignal5906.05.62,479
product dose omission issueSignal1,0745.75.44,237
inappropriate schedule of product administrationSignal5464.84.41,624
decreased appetiteSignal5313.63.3996
pyrexiaSignal6322.92.7775
vomitingSignal8522.82.71,035
diarrhoeaSignal1,0612.62.41,052
nauseaSignal1,1062.22.1740
death7781.41.398

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.